Literature DB >> 28942660

Pathways to the elimination of hepatitis C: prioritising access for all.

Alisa E Pedrana1,2, Rachel Sacks-Davis1,3, Joseph S Doyle1,4, Margaret E Hellard1,4.   

Abstract

Keywords:  Cost-effectiveness; IDU; disease elimination; hepatitis C virus; implementation science; models of care; testing

Mesh：

Substances：

Year:  2017        PMID： 28942660     DOI： 10.1080/17512433.2017.1383894

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN： 1751-2433            Impact factor:   5.045


× No keyword cloud information.
  2 in total

1.  2017 international meeting of the Global Virus Network.

Authors:  Mike Catton; Glenda Gray; Diane Griffin; Hideki Hasegawa; Stephen J Kent; Jason Mackenzie; Edward McSweegan; Natalia Mercer; Linfa Wang
Journal:  Antiviral Res       Date:  2018-02-05       Impact factor: 5.970

2.  Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocol.

Authors:  Tafireyi Marukutira; Karen P Moore; Margaret Hellard; Jacqui Richmond; Kate Turner; A E Pedrana; Shannon Melody; Fay H Johnston; Louise Owen; Wijnand Van Den Boom; N Scott; Alexander Thompson; David Iser; Tim Spelman; Mark Veitch; Mark A Stoové; Joseph Doyle
Journal:  BMJ Open       Date:  2022-03-25       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.